Episode

When Drug Marketing Masquerades as Clinical Trials

Podcast
Neurology® Podcast
Published
Jul 13, 2026
Duration seconds
1049
Processing state
not_requested
Canonical source
https://neurology.libsyn.com/when-drug-marketing-masquerades-as-clinical-trials
Audio
https://traffic.libsyn.com/secure/neurology/NEW_Neurology_Podcast_-_July_14th_2026_v2.mp3?dest-id=937793
JSON
/v1/public/podcasts/neurology-podcast-635512/episodes/when-drug-marketing-masquerades-as-clinical-trials
Markdown
/podcast/neurology-podcast-635512/when-drug-marketing-masquerades-as-clinical-trials.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/when-drug-marketing-masquerades-as-clinical-trials/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neurology-podcast-635512/when-drug-marketing-masquerades-as-clinical-trials.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Read the related article on The Conversation . Disclosures can be found at Neurology.org .